Effects of a single, daily alcoholic beverage on lipid and hemostatic markers of cardiovascular risk

Am J Cardiol. 1997 Nov 1;80(9):1226-8. doi: 10.1016/s0002-9149(97)00647-4.

Abstract

There is substantial epidemiologic data, but limited experimental data, supporting the mortality benefit of low-dose alcohol consumption. A regimen of a single, daily alcoholic beverage was sufficient to increase both high-density lipoprotein (HDL) (4.4%, p = 0.03) and HDL2 (7.7%, p = 0.04) in men and women, but did not significantly affect hemostatic markers of cardiovascular risk.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Alcohol Drinking*
  • Beer
  • Blood Coagulation Factors / analysis*
  • Cardiovascular Diseases / blood*
  • Cardiovascular Diseases / epidemiology*
  • Cholesterol, HDL / blood*
  • Female
  • Humans
  • Lipoproteins / blood*
  • Male
  • Middle Aged

Substances

  • Blood Coagulation Factors
  • Cholesterol, HDL
  • Lipoproteins